Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Cash from Financing Activities (2016 - 2026)

Ekso Bionics Holdings has reported Cash from Financing Activities over the past 13 years, most recently at $2.9 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 1030.25% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.6 million, a 14.67% decrease, with the full-year FY2025 number at $6.6 million, down 14.67% from a year prior.
  • Cash from Financing Activities reached $2.9 million in Q4 2025 per EKSO's latest filing, up from -$437000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $38.7 million in Q1 2021, with the low at -$437000.0 in Q3 2025.
  • The 4-year median for Cash from Financing Activities is $1.8 million (2025), against an average of $5.3 million.
  • Peak YoY movement for Cash from Financing Activities: soared 6672.5% in 2021, then tumbled 190.23% in 2024.
  • Tracing EKSO's Cash from Financing Activities over 4 years: stood at $38.7 million in 2021, then crashed by 99.1% to $348000.0 in 2023, then plummeted by 190.23% to -$314000.0 in 2024, then soared by 1030.25% to $2.9 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $2.9 million, -$437000.0, and $616000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.